Indian business district at morning, illustrating market and economic activity
    Investing WisdomJun 27, 2015•2 min read

    Maxify Pharma — Why Most Investors Don't Come Close to Earning Average Returns

    Introducing Maxify Pharma, a retail product investing exclusively in pharma stocks, built with Research Delta Advisors.

    Portrait of Tejas Shah

    Tejas Shah

    Tejas Shah is the Founder and Managing Partner of Silicon One and Proprietor of Silicon Systems, based in Vadodara, Gujarat.

    The most frequent question clients ask is: "Is it a good time to invest?" When markets are down, investors worry and want to wait. When markets are up, they worry about buying just before a correction. When markets go sideways, they wait for some other reason. As Peter Lynch once said: there is always something to worry about.

    A pharma-focused offering

    Silicon One has roped in Research Delta Advisors, a boutique investment advisory focused on the Indian pharmaceutical sector, to bring out "Maxify Pharma" — a long-term wealth creation solution investing only in pharma stocks. Research Delta's founder has roughly 17 years of experience researching the sector, advising pharma companies on strategic initiatives and mutual fund managers on their pharma investments.

    We look forward to seeing you invest with us. Happy investing! — Tejas Shah, Managing Partner, Silicon One.

    #financial planning#investing#mutual fund#mutual funds#retirement

    Share this article

    Enjoyed this article?

    Subscribe to receive more insights like this directly in your inbox.